Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Life Science Awards.
Sort by 
AstraZeneca’s ambitious growth target to boost Ireland and the UK
Author: Chris Wheal
Focus on R&D and new product development at the heart of 2030 targets
Ireland to streamline clinical trials to target faster patient access to treatments
Author: April Lara
New contract aims to remove the roadblock to faster clinical trials.
Clinical trials boost demanded so Irish get faster access to life-saving treatments
Author: Chris Wheal
Finland and Denmark have similar populations and economic wealth to Ireland but get far more clinical trials.
Insights from Dr. Laszlo Fabian: Judging the Pharma Industry Awards
Author: April Lara
The Pharma Industry Awards judge Dr Laszlo Fabian, from the University of East Anglia, shares his insights on his background, judging criteria, and the importance of collaboration.
Pfizer is in the firing line for UK complaints but is it one individual or lobby group time-wasting?
Author: Chris Wheal
Who is behind the string of anonymous complaints to the UK regulator? We try to find out and examine how the UK code is policed.
Biostór on quality and the future of healthcare
Author: April Lara
Biostór, a shortlisted Pharma Industry Awards candidate, shares its approach to quality and vision for the future of healthcare.
Janssen is to rebrand as Johnson & Johnson Innovative Medicine
Author: Chris Wheal
Janssen UK will immediately be known as Johnson & Johnson Innovative Medicine, with Ireland switching over in June.
Ireland’s pharma firms are EU’s third biggest exporter to the rest of the world
Author: Chris Wheal
The latest Eurostat figures show how important Ireland’s pharma sector is.
From Waterford to the world: stability storage firm Q1 Scientific on expansion into Belgium
Author: April Lara
Fresh from The Pharma Industry Awards, Q1 Scientific’s marketing manager, Karrena Legg, shares details on the storage specialist’s strategic move into Belgium.
Pharma and medical device makers have a ‘conflict of interest’ over health education funding
Author: Chris Wheal
Industry denies funding education and research in healthcare organisations presents a conflict of interest.
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
